Thank you for joining us to discuss fourth quarter and fiscal year 2025 results, which we released before the U.S. market opened today. On the call with me today are our CEO, Dr. David Wang; our CFO, ...
A look at the biologics, gene therapies, and vaccines most likely to reshape care —and manufacturing—in the year ahead.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果